Identification of an Individualized Metabolism Prognostic Signature and Related Therapy Regimens in Early Stage Lung Adenocarcinoma

OBJECTIVE: The choice of adjuvant therapy for early stage lung adenocarcinoma (LUAD) remains controversial. Identifying the metabolism characteristics leading to worse prognosis may have clinical utility in offering adjuvant therapy. METHODS: The gene expression profiles of LUAD were collected from...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Junjie, Yu, Huansha, Sun, Liangdong, Yan, Yilv, Zhang, Lele, Jiang, Gening, Zhang, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113858/
https://www.ncbi.nlm.nih.gov/pubmed/33996569
http://dx.doi.org/10.3389/fonc.2021.650853

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113858/
https://www.ncbi.nlm.nih.gov/pubmed/33996569
http://dx.doi.org/10.3389/fonc.2021.650853

Ejemplares similares